60th Annual Meeting of the Japanese Society of Neurology

Presentation information

Oral Session

[O-09] Clinical trial and Regenerative medicine1

Wed. May 22, 2019 3:35 PM - 5:05 PM Room 12 (Osaka International Convention Center 11F Conference Room 1101-1102)

Chair:Takanori Yokota(Tokyo Medical and Dental University)

[O-09-4] Progression status of Japan Early-stage Trial of high dose methylcobalamin for ALS (JETALS)

Ryosuke Oki1, Yuishin Izumi1, Hiroyuki Nodera1, Yasutaka Sato2, Hiroshi Nokihara2, Hiroaki Yanagawa2, Satoshi Kuwabara3, Ryuji Kaji4, JETALS collaborators5 (1.Department of Clinical Neuroscience, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan., 2.Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan., 3.Department of Neurology, Chiba University Graduate School of Medicine, Chiba, Japan, 4.Utano National Hospital, National Hospital Organization, Kyoto, Japan., 5.JETALS collaborators)

Abstract password authentication.
Password is written on a pocket program and name badge.

Password